Epilepsy and paroxysmal conditions

Advanced search


Full Text:

About the Author

О. S. Davydov
The Institute of General Pathology and Pathophysiology, Moscow
Russian Federation


1. Perkins B.D. The Influence of Metallic Tractors on the Human Body, in removing various painful inflammatory diseases, such as rheumatism, pleurisy, some gouty affections, &c. &c.: Lately discovered by Dr. Perkins, of North America, and demonstrated in a series of experiments and observations, by professors Meigs, Woodward, Rogers, &c. &c.: by which the importance of the discovery is fully ascertained, and a new field of enquiry opened in the modern science of galvanism, or, animal electricity. 1798; Printed for J. Johnson and Ogilvy and Son, London; Reprint: ECCO (Eighteenth Century Collections Online) Print Editions 2011, LaVergne, Tennessee.

2. Haygarth J. Of the imagination, as a cause and as a cure of disorders of the body; exemplified by fictitious tractors, and epidemical convulsions. Read to the literary and philosophical society of bath. 1800; Bath, Cruttwell; Reprint: ECCO [Eighteenth Century Collections Online] Print Editions 2011, LaVergne, Tennessee.


4. Shapiro A. The placebo effect. In: Principles of Psychopharmacology. N.Y. 1978; 441-459.

5. Лапин И.П. Плацебо и терапия. Спб. 2000; 8-12, 46-49.

6. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb; 15; 90 (3): 205-15.

7. Haltia L.T., Rinne J.O., Helin S., Parkkola R., Nagren K., Kaasinen V. Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function. Synapse. 2008; 62 (9): 682-8.

8. Petrovic P., Kalso E., Petersson K.M., Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science. 2002 Mar 1; 295 (5560): 1737-40.

9. Murray D., Stoessl A.J. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions, Pharmacol. Ther. 2013 Dec; 140 (3): 306-18.

10. Marson A.G., Kadir Z.A., Chadwick D.W. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ. 1996 Nov 9; 313 (7066): 1169-74.

11. Burneo J.G., Montori V.M., Faught E. Magnitude of the placebo effect in randomized trials of antiepileptic agents. Epilepsy Behav. 2002; 3: 532-4.

12. Beyenburg S., Stavem K., Schmidt D. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis. Epilepsia. 2010; 51: 7-26.

13. Guekht A.B., Korczyn A.D., Bondareva I.B., Gusev E.I. Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav. 2010; 17: 64-9.

14. Rheims S., Cucherat M., Arzimanoglou A., Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med. 2008 Aug 12; 5 (8): e166.

15. Tachibana Y., Narukawa M. Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis. Clin Drug Investig. 2013 May; 33(5): 315-24.

16. Pollo A., Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. Prog Brain Res. 2009; 175: 283-94.

17. Thomas K.B. General practice consultations: is there any point in being positive? Br Med J. 1987; 294: 1200-1202.

18. Amanzio M., Pollo A., Maggi G., Benedetti F. Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain. 2001 Feb15; 90 (3): 205-15.

19. Branthwaite A., Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed). 1981 May 16; 282 (6276): 1576-8.

20. Schmidt D., Beyenburg S., DSouza J., Stavem K. Clinical features associated with placebo response in refractory focal epilepsy. Epilepsy Behav. 2013; 27: 393-398.

21. French J., Brandt C., Friedman D., Biton V., Knapp L., Pitman V., Chew M., Dubrava S., Posner H.B. Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial. Epilepsia. 2014 Jun 24. doi: 10.1111/epi.12690. [Epub ahead of print].

22. Arnold L.M., Arsenault P., Huffman C., Patrick J.L., Messig M., Chew M.L., Sanin L., Scavone J.M., Pauer L., Clair A.G. Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a Phase III, double-blind, randomized withdrawal, placebo-controlled study. Curr Med Res Opin. 2014 May 27; 1-35.



For citations:

Davydov О.S. . Epilepsy and paroxysmal conditions. 2014;6(3):50-53. (In Russ.)

Views: 495

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)